Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats G Nowak, B Szewczyk, JM Wieronska, P Branski, A Palucha, A Pilc, ... Brain research bulletin 61 (2), 159-164, 2003 | 216 | 2003 |
Multiple MPEP administrations evoke anxiolytic-and antidepressant-like effects in rats A Pilc, A Kłodzińska, P Brański, G Nowak, A Pałucha, B Szewczyk, ... Neuropharmacology 43 (2), 181-187, 2002 | 182 | 2002 |
Group III mGlu receptor agonists produce anxiolytic-and antidepressant-like effects after central administration in rats A Pałucha, E Tatarczyńska, P Brański, B Szewczyk, JM Wierońska, K Kłak, ... Neuropharmacology 46 (2), 151-159, 2004 | 159 | 2004 |
Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist A Pałucha, P Brański, B Szewczyk, JM Wierońska, K Kłak, A Pilc Pharmacology Biochemistry and Behavior 81 (4), 901-906, 2005 | 151 | 2005 |
Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats K Ossowska, J Konieczny, S Wolfarth, J Wierońska, A Pilc Neuropharmacology 41 (4), 413-420, 2001 | 148 | 2001 |
A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long‐term paraquat administration in rats: an animal model of preclinical stages of Parkinson's … K Ossowska, J Wardas, M Śmiałowska, K Kuter, T Lenda, JM Wierońska, ... European Journal of Neuroscience 22 (6), 1294-1304, 2005 | 144 | 2005 |
Glutamate-based antidepressants: preclinical psychopharmacology A Pilc, JM Wierońska, P Skolnick Biological psychiatry 73 (12), 1125-1132, 2013 | 139 | 2013 |
Interaction of zinc with antidepressants in the forced swimming test in mice B Szewczyk, P Brañski, JM Wieroñska, A Palucha, A Pilc, G Nowak Polish journal of pharmacology 54 (6), 681-686, 2002 | 105 | 2002 |
Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs JM Wierońska, A Pilc Neurochemistry international 55 (1-3), 85-97, 2009 | 101 | 2009 |
Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats K Kuter, M Śmiałowska, J Wierońska, B Zięba, J Wardas, M Pietraszek, ... Brain Research 1155, 196-207, 2007 | 93 | 2007 |
Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson’s … K Ossowska, M Śmiałowska, K Kuter, J Wierońska, B Zięba, J Wardas, ... Neuroscience 141 (4), 2155-2165, 2006 | 91 | 2006 |
Antidepressant‐like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents G Nowak, A Partyka, A Pałucha, B Szewczyk, JM Wierońska, M Dybała, ... British journal of pharmacology 149 (5), 581-590, 2006 | 81 | 2006 |
Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in the rat hippocampus in an animal model of depression B Szewczyk, A PA, M UCHA, P GRUCA, E MORYL Pol. J. Pharmacol 53, 659-662, 2001 | 77 | 2001 |
Effects of South African traditional medicine in animal models for depression ME Pedersen, B Szewczyk, K Stachowicz, J Wieronska, J Andersen, ... Journal of Ethnopharmacology 119 (3), 542-548, 2008 | 75 | 2008 |
Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats JM Wieronska, B Szewczyk, P Branski, A Palucha, A Pilc Amino acids 23, 213-216, 2002 | 75 | 2002 |
Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus M Śmiałowska, B Szewczyk, P Brański, JM Wierońska, A Pałucha, ... Neuropharmacology 42 (8), 1016-1023, 2002 | 74 | 2002 |
Antidepressant-like activity of amisulpride in two animal models of depression M Papp, J Wieronska Journal of Psychopharmacology 14 (1), 46-52, 2000 | 70 | 2000 |
Anxiolytic-and antidepressant-like effects of group III metabotropic glutamate agonist (1S, 3R, 4S)-1-aminocyclopentane-1, 3, 4-tricarboxylic acid (ACPT-I) in rats E Tatarczyñska, A Palucha, B Szewczyk, E Chojnacka-Wójcik, ... Polish journal of pharmacology 54 (6), 707-710, 2002 | 67 | 2002 |
Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia JM Wierońska, K Stachowicz, F Acher, T Lech, A Pilc Psychopharmacology 220, 481-494, 2012 | 64 | 2012 |
Metabotropic glutamate receptors as targets for new antipsychotic drugs: historical perspective and critical comparative assessment JM Wierońska, SH Zorn, D Doller, A Pilc Pharmacology & therapeutics 157, 10-27, 2016 | 61 | 2016 |